Imaging assisted Radiation for Cervical Cancers

Image Guided Radiation Therapy (IGRT) in Cervical Cancers - IGRT Trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/02/003373

Enrollment

Registered

2013-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with FIGO stage I - III B cervical cancer

Interventions

Intervention1: EBRT +/- Chemotherapy followed by Brachytherapy: EBRT: 3D CRT/IMRT/ Volumetric Arc Therapy- 46-50 Gy/ 23-25# over 5 weeks. Chemotherapy: Weekly Inj. Cisplatin (40mg/m2)throughout the co

Eligibility

Inclusion criteria

Inclusion criteria: Histologically - proven, invasive cervical cancer with clinical FIGO stage I â?? IIIB after thorough clinical examination and work-up investigations (hematological and Imaging) Suitable for radical radiation therapy with / without concomitant chemotherapy Written Informed Consent

Exclusion criteria

Exclusion criteria: Previous history of hysterectomy for benign lesions / cervical cancer Vault Cancers / recurrences Previous history of pelvic radiation Non â?? compliance to treatment Medical or psychological illness precluding treatment protocol History of allergy / claustrophobia / implants for imaging studies Pregnancy and breast feeding.

Design outcomes

Primary

Measure	Time frame
IGRT in cervical cancersTimepoint: IGRT in cervical cancers	—

Secondary

Measure	Time frame
Planned Adaptive models with determination of organ motion and tumor regression in cervical cancersTimepoint: NA	—

Countries

India

Contacts

Public ContactDr Umesh Mahantshetty

Tata Memorial Hospital

radonco@tmc.gov.in24177163

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026